Journal article icon

Journal article

Clinical stem cell therapies for severe autoimmune diseases.

Abstract:

Severe autoimmune diseases (ADs) are a major source of disability and reduced quality of life and may result in shortened life expectancy, particularly in treatment-resistant patients. For several decades, allogeneic and autologous haematopoietic stem cell transplantation (HSCT) has been the focus of scientific investigation as a potential means of delivering 'one-off' intensive treatment in severe ADs. Improvements in the clinical safety of HCST were followed by its increasing use in recent ...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Snowden, JA More by this author
Martin-Rendon, E More by this author
Journal:
Transfusion medicine (Oxford, England)
Volume:
19
Issue:
5
Pages:
223-234
Publication date:
2009-10-05
DOI:
EISSN:
1365-3148
ISSN:
0958-7578
URN:
uuid:18d1e983-ce29-49e4-a085-6abe2f33b0fe
Source identifiers:
324156
Local pid:
pubs:324156

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP